NEU 0.54% $20.10 neuren pharmaceuticals limited

Acadia, page-60

  1. 453 Posts.
    lightbulb Created with Sketch. 50
    Personally I don't want a T/O this time next year unless it is extremely generous.
    If March decision is as we expect and the Phase 2 trials are very promising then I would rather see us licence them and see them through Phase 3 at least and perhaps a partnership with free carry in one or two of the most promising of the stable.

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.